CELG Celgene Corporation

  • CELG
  • Price as of: Jan 23, 04:00 PM EST
  • $112.31
  • -$0.35
  • -0.3%
  • Industry
  • Drug manufacturers - major

CELG Stock Dividend Data

Add CELG to Watchlist
  • Dividend Yield
    0.00% Healthcare Average 0.91%
  • Annualized Payout
  • Payout Ratio
    0.0% EPS $5.28
  • Dividend Growth
    No Payout Increase Last Year
  • Get CELG DARS™ Rating

Looking to buy or sell CELG?

Buy Now
Sell Now
Upcoming Dividend Payouts

CELG Upcoming Dividend Payouts

CELG has not yet officially announced its next dividend payout.
DARS Rating™ Breakdown

Dividend.com DARS Rating™ Breakdown for CELG

Metric Ranking Avg Ranking Notes
Stock not rated.
Yield History

CELG Dividend Yield & Stock Price History

Dividend Payout History

CELG Dividend Payout History

No Payout History Is Available

Brought to You by Mitre Media

Growth History

CELG Dividend Growth History

Annualized Growth
Annualized Growth
Annualized Growth
Annualized Growth
Annualized Growth
Last 5 Yrs
Annualized Growth
Last 3 Yrs
Years of
Reveal More Dividend Growth History for CELG
Historical Annual Dividend Data & Growth

CELG Historical Annual Dividend Data & Growth

Payout Amount Calendar Year Annual Growth
No Payout History Is Available
Historical Dividend Data

CELG Dividend History

Payout Amount Declared Date Ex-Dividend Date Record Date Pay Date ▼ Qualified Dividend? Payout Type Frequency
No Payout History Is Available

Knowledge Centers

Company Profile

CELG Company Profile

Exchange: NASDAQ
Sector: Healthcare

High Yield Stocks

High Yield Stocks

Looking for dividend stocks with great yields? Visit our list of:

High Yield Dividend Stocks

Celgene Corporation News

  • The analysts here at Dividend.com analyzed the search patterns of visitors to our site during the past week ending October 2, 2015. Below we give an analysis of how intelligently users used Dividend.com to help them in their investment...

  • When investors think of biotech stocks, the word “lottery” comes to mind. And for the most part, they are right. The vast bulk of the sector made up of smaller, early-stage drug developers with only one, or maybe two, new therapies in development....

  • Hoping everyone enjoyed had a good Father's Day weekend. Time to get back to business and what may be moving the markets as we start a new week....